Loading…
Loading…
Connecticut · Nonprofit
THE MULTIPLE MYELOMA RESEARCH (Connecticut) is funded by 387 grantmakers whose IRS filings report $52,439,129 in grants to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($6,934,621). 191 of them have funded it in more than one year.
Against its field
THE MULTIPLE MYELOMA RESEARCH is better cushioned than half of the 3,322 health nonprofits its size.
this organization peer median middle 50% of peers· 3,322 health nonprofits $10M–$100M, FY2024
Revenue, expenses and net assets — each indexed to 100 at its first filing year, so you read the trajectory, not the magnitude. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
The funding model — what share of revenue comes from contributions, programs, investments and other sources — and whether it's shifting.
83% of THE MULTIPLE MYELOMA RESEARCH’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
$730k from 12 funders in 2025, up from $1.9M and 78 in 2017.
53 of 387 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 53% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of THE MULTIPLE MYELOMA RESEARCH’s funders (the co-funder graph). Top 30 of 387 funders by total. Association, not causation.
THE MULTIPLE MYELOMA RESEARCH has a broad base — no single funder exceeds 13% of grant income, and it takes 6 funders to reach half.
the vertical line marks half of all grant income — 6 funders to its left
Largest funder’s share by year: 2017 35% · 2018 33% · 2019 35% · 2020 33% · 2021 27% · 2022 21% · 2023 32% · 2024 13% · 2025 48% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration.
26% of THE MULTIPLE MYELOMA RESEARCH's funders are still giving 3 years after their first grant; 49% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year.
THE MULTIPLE MYELOMA RESEARCH draws 99% of its grant income from funders outside Connecticut — its reputation reaches beyond the state, across 33 states in all.
In-state vs out-of-state, by year
Grantmakers that don’t fund you yet, surfaced two ways: they back organizations that share your funders, or their grantees resemble your mission. The ones both signals agree on come first. Your 387 funders put you typical among the 400 organizations that share them.
From the co-funder graph (funders backing at least two comparable organizations, shrunk for grantee count, donor-advised and mega-funds excluded) and the universe embeddings. A research starting point; overlap is association, not a guarantee of fit.
Nonprofits whose mission and program text most resemble this one, by semantic similarity over the universe of US filings — the closest peers, and often the clearest route to shared or prospective funders.
Read directly from this organization’s own Form 990, as neutral context.
82% of spending goes to programs.
85%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Operates in 25 states
Part of a family of 2 related entities
Every figure is read directly from IRS Form 990 / 990-PF e-file XML — this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 387funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. view filing